Meinian Onehealth Healthcare Holdings Co Ltd

Meinian Onehealth Healthcare’s 2025 Q3 earnings reveal a mix of growth prospects and valuation caution—high P/E, robust market cap, and evolving health‑service portfolio.

Explore why Shanghai’s Meinian Onehealth, a mid‑market healthcare player with a high P/E and low liquidity, remains overlooked, and what investors need to know about its risk and potential for long‑term value.